Delhi-based healthtech startup Remedo has raised an undisclosed amount in its pre-Series A round from River Rock Ventures.

The funding round also saw participation from Inflection Point Ventures along with other investors including AngelList, Mitesh Daga (TPG Capital), Mohit Satyanand, and Aditya Vij (Kedara capital).

Co-Founded by Harsh Bansal, Dr Ruchir Mehra, and Richeek Arya, Remedo is a Delhi-based healthtech startup that helps doctors engage with patients. The platform improves patient experience, thus helping doctors in their practice.

Remedo plans to use the funds to expand into other specialities like neuro, cardiovascular and respirators.

Addressing the present COVID-19 and acceptance of telemedicine among people, Dr Ruchir Mehra, (Co-founder- Remedo) said,

“Because of COVID outbreak, patients are unable to meet their doctors in person as it is not advisable to visit hospitals if one is not a corona affected case. As a result, we have seen a clear acceptance among the stakeholders to take the telemedicine route. Our business has witnessed 17% growth in follow up visits for the doctors on the platform.”